Multiple Ascending Dose Study of TMP-301 in Healthy Subjects
Status:
Completed
Trial end date:
2024-01-02
Target enrollment:
Participant gender:
Summary
A PHASE 1, RANDOMIZED, PLACEBO CONTROLLED, MULTIPLE ASCENDING DOSE (MAD) STUDY TO EVALUATE
THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF TMP-301 IN HEALTHY SUBJECTS.